These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 30355150)

  • 21. Detection of Abnormal Prion Protein by Immunohistochemistry.
    Orge L; Lurdes Pinto M; Cristovão P; Mendonça P; Carvalho P; Lima C; Santos H; Alves A; Seixas F; Pires I; Gama A; Dos Anjos Pires M
    J Vis Exp; 2023 May; (195):. PubMed ID: 37212578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion protein and the molecular features of transmissible spongiform encephalopathy agents.
    Silveira JR; Caughey B; Baron GS
    Curr Top Microbiol Immunol; 2004; 284():1-50. PubMed ID: 15148986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prions and prion diseases: fundamentals and mechanistic details.
    Ryou C
    J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey and a molecular dynamics study on the (central) hydrophobic region of prion proteins.
    Zhang J; Wang F
    Curr Pharm Biotechnol; 2014; 15(11):1026-48. PubMed ID: 25373387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurodegeneration in humans caused by prions.
    Prusiner SB
    West J Med; 1994 Sep; 161(3):264-72. PubMed ID: 7975565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine spongiform encephalopathy, chronic wasting disease, scrapie, and the threat to humans from prion disease epizootics.
    Bosque PJ
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):488-95. PubMed ID: 12359101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of pathological prion protein accumulation in the brain of moose (Alces alces) from Norway, Sweden and Finland with chronic wasting disease.
    Sola D; Tran L; Våge J; Madslien K; Vuong TT; Korpenfelt SL; Ågren EO; Averhed G; Nöremark M; Sörén K; Isaksson M; Acín C; Badiola JJ; Gavier-Widén D; Benestad SL
    Vet Res; 2023 Sep; 54(1):74. PubMed ID: 37684668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of CWD strains.
    Otero A; Duque Velasquez C; McKenzie D; Aiken J
    Cell Tissue Res; 2023 Apr; 392(1):135-148. PubMed ID: 36201049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
    Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions.
    Barria MA; Libori A; Mitchell G; Head MW
    Emerg Infect Dis; 2018 Aug; 24(8):1482-1489. PubMed ID: 30014840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human prion diseases. A review with special emphasis on new variant CJD and comments on surveillance.
    Keohane C
    Clin Exp Pathol; 1999; 47(3-4):125-32. PubMed ID: 10472732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion diseases.
    McKintosh E; Tabrizi SJ; Collinge J
    J Neurovirol; 2003 Apr; 9(2):183-93. PubMed ID: 12707849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter- and intra-species conversion efficacies of Norwegian prion isolates estimated by serial protein misfolding cyclic amplification.
    Harpaz E; Vuong TT; Tran L; Tranulis MA; Benestad SL; Ersdal C
    Vet Res; 2023 Sep; 54(1):84. PubMed ID: 37773068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenic mechanisms of prion diseases.
    Hur K; Kim JI; Choi SI; Choi EK; Carp RI; Kim YS
    Mech Ageing Dev; 2002 Nov; 123(12):1637-47. PubMed ID: 12470901
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines for prion diseases: a realistic goal?
    Napper S; Schatzl HM
    Cell Tissue Res; 2023 Apr; 392(1):367-392. PubMed ID: 36764940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Winter Ticks (Dermacentor albipictus) Collected from North American Elk (Cervus canadensis) in an Area of Chronic Wasting Disease Endemicity for Evidence of PrP
    Haley NJ; Henderson DM; Senior K; Miller M; Donner R
    mSphere; 2021 Aug; 6(4):e0051521. PubMed ID: 34346708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.
    Kurt TD; Bett C; Fernández-Borges N; Joshi-Barr S; Hornemann S; Rülicke T; Castilla J; Wüthrich K; Aguzzi A; Sigurdson CJ
    J Neurosci; 2014 Jan; 34(3):1022-7. PubMed ID: 24431459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.